Log in to save to my catalogue

350 Effects of GLP-1 Agonist on Pediatric Populations in a Real-World Setting

350 Effects of GLP-1 Agonist on Pediatric Populations in a Real-World Setting

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ac14c4d1ae51445ea89c0ee6a6fdfba0

350 Effects of GLP-1 Agonist on Pediatric Populations in a Real-World Setting

About this item

Full title

350 Effects of GLP-1 Agonist on Pediatric Populations in a Real-World Setting

Publisher

Cambridge: Cambridge University Press

Journal title

Journal of clinical and translational science, 2024-04, Vol.8 (s1), p.106-106

Language

English

Formats

Publication information

Publisher

Cambridge: Cambridge University Press

More information

Scope and Contents

Contents

OBJECTIVES/GOALS: Compare metabolic health of type 2 diabetics on GLP-1 to those on traditional therapy METHODS/STUDY POPULATION: Outcomes of interest of this study include analyzing GLP-1 agonists on overall metabolic health, focusing primarily on weight loss and ability to wane off insulin without rebounding metabolic health. The data will be col...

Alternative Titles

Full title

350 Effects of GLP-1 Agonist on Pediatric Populations in a Real-World Setting

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ac14c4d1ae51445ea89c0ee6a6fdfba0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ac14c4d1ae51445ea89c0ee6a6fdfba0

Other Identifiers

ISSN

2059-8661

E-ISSN

2059-8661

DOI

10.1017/cts.2024.312

How to access this item